CD79A and stage 5 chronic kidney disease: With regard to disease associations of particular isotypes, an increased prevalence of IgA anti-B2GPI has been reported in a variety of disorders such as autoimmune hepatitis, coeliac disease, metabolic syndrome, and haemodialysed patients with end stage renal failure [36,37,38,39].